Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study was to evaluate the potential for phototoxicity of the sun care products SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 compared to that of a negative control (0.9% sodium chloride [NaCl]) after a single 24 h application of test materials followed by irradiation with ultraviolet A (UVA) and ultraviolet B (UVB).

The secondary objective of this study was to evaluate the safety of the sun care products SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 combined with UVA/B irradiation by monitoring adverse events (AEs) throughout the study.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02802930
Study type Interventional
Source Bayer
Contact
Status Completed
Phase N/A
Start date April 20, 2015
Completion date April 26, 2015

See also
  Status Clinical Trial Phase
Completed NCT02872194 - Evaluation of the Stinging Potential of Products in Human Eyes N/A
Completed NCT05004168 - Sun Protection Factor (SPF) / UVA Protection Factor Study N/A
Completed NCT02872246 - Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) - Assay N/A
Completed NCT02872233 - Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay N/A
Completed NCT02857738 - Sun Protection Factor (SPF) - Static and Water Resistant Assay N/A
Completed NCT02857725 - Sun Protection Factor (SPF) Assay N/A
Completed NCT02857478 - Supervised Outdoor-Use Test to Assess the Safety of a Sunscreen C-Spray on Sport Users N/A
Completed NCT02885805 - Sun Protection Factor (SPF) Efficacy Assay N/A
Completed NCT02869113 - Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes N/A
Completed NCT02872207 - Evaluation of the Stinging Potential in Human Eyes N/A